Intraarticular Injection

Compared with placebo, viscosupplementation provided a small reduction in pain but increased risk of serious adverse events in patients with knee osteoarthritis, according to published results.

Platelet-rich plasma injections failed to improve knee osteoarthritis symptoms or joint structure at 12 months, compared with a saline placebo, in patients with symptomatic, mild-to-moderate radiographic disease, according to data.

A recent meta-analysis demonstrated the negative effects of musculoskeletal pain on sexual function, intimate relationships, sexual identity, body image and self-worth. It was the top story in rheumatology last week.

Just 23% of Medicare beneficiaries with osteoarthritis who eventually underwent knee replacement ever had a physical therapy visit, according to data published in Arthritis & Rheumatology.

In an effort to “improve uniformity” and reduce the “wide variation” in intra-articular therapy use, EULAR recently published 11 new recommendations to guide clinicians in employing these therapies for patients with peripheral arthropathies.

A speaker at the 2021 OARSI World Congress said intraarticular injections of platelet-rich plasma or cell therapies could be effective alternatives to traditional modalities for osteoarthritis. It was the top story in rheumatology last week.

Understanding the complex associations between pain, function and structural factors in the joints may allow clinicians to use intraarticular injections more effectively in osteoarthritis, according to a speaker at the 2021 OARSI World Congress.

Intra-articular injection of amniotic membrane/umbilical cord particulate may reduce pain and improve function in patients with moderate to severe knee osteoarthritis, according to published results.

Physicians often weigh the uncertain efficacy of injectable drugs, and patients’ expectations, before offering intra-articular injections for osteoarthritis, according to findings published in Arthritis Care & Research.

Patients with juvenile idiopathic arthritis who were placed in a splint to encourage rest following intra-articular corticosteroid injection, or IACI, demonstrated no significant benefit against recurrent arthritis compared with those who were not given a splint, according to findings published in Pediatric Rheumatology.